AURO-CEFIXIME TABLET

Ülke: Kanada

Dil: İngilizce

Kaynak: Health Canada

Aktif bileşen:

CEFIXIME

Mevcut itibaren:

AURO PHARMA INC

ATC kodu:

J01DD08

INN (International Adı):

CEFIXIME

Doz:

400MG

Farmasötik formu:

TABLET

Kompozisyon:

CEFIXIME 400MG

Uygulama yolu:

ORAL

Paketteki üniteler:

7/10/20/500

Reçete türü:

Prescription

Terapötik alanı:

THIRD GENERATION CEPHALOSPORINS

Ürün özeti:

Active ingredient group (AIG) number: 0122105003; AHFS:

Yetkilendirme durumu:

APPROVED

Yetkilendirme tarihi:

2014-10-17

Ürün özellikleri

Page 1 of 29
PRODUCT MONOGRAPH
PR
AURO-CEFIXIME
CEFIXIME TABLETS 400 MG
MANUFACTURER’S STANDARD
ANTIBIOTIC
AURO PHARMA INC.
DATE OF REVISION:
3700 Steeles Avenue West, Suite # 402 June 10, 2020
Woodbridge, Ontario, L4L 8K8
CANADA
Submission Control No:
239324
Page 2 of 29
PRODUCT MONOGRAPH
PR
AURO-CEFIXIME
Cefixime Tablets
400 mg
Manufacturer’s Standard
THERAPEUTIC CLASSIFICATION
Antibiotic
ACTION AND CLINICAL PHARMACOLOGY
Cefixime exerts its bactericidal effect by attaching to
penicillin-binding proteins (PBP) and
inhibiting peptidoglycan synthesis, thus causing damage to the
bacterial cell wall.
Following oral dosing, cefixime attains peak serum levels in
approximately 4 hours. The half-life
is about 3 to 4 hours and is not dose dependent. Cefixime is excreted
by renal and biliary
mechanisms. About 50% of the absorbed dose is excreted unchanged in
the urine within 24 hours.
There is no evidence of metabolism of cefixime in vivo.
INDICATIONS AND USAGE
AURO-CEFIXIME (cefixime) is indicated in the treatment of the
following infections caused by
susceptible strains of the designated microorganisms:
UPPER RESPIRATORY TRACT:
Pharyngitis and tonsillitis caused by
_S. pyogenes_
.
MIDDLE EAR:
Otitis media caused by
_S. pneumoniae_
,
_H. influenzae_
(beta-lactamase positive and negative
strains),
_M. catarrhalis_
(former
_B. catarrhalis_
) (beta-lactamase positive and negative strains) and
_S. pyogenes_
.
PARANASAL SINUSES:
Sinusitis caused by
_S. pneumoniae_
,
_H. influenzae_
(beta-lactamase positive and negative strains),
and
_M. catarrhalis_
(former
_B. catarrhalis_
) (beta-lactamase positive and negative strains).
LOWER RESPIRATORY TRACT:
Acute bronchitis caused by
_S. pneumoniae_
,
_M. catarrhalis_
(former
_B. catarrhalis_
) (beta-lactamase
positive and negative strains) and
_H. influenzae_
(beta-lactamase positive and negative strains).
Page 3 of 29
URINARY TRACT:
Acute uncomplicated cystitis and urethritis caused by
_E. coli_
,
_P. mirabilis_
, and
_Klebsiella_
species.
UNCOMPLICATED GONORRHEA:
Uncomplicated g